EULAV Asset Management
- SEC CIK
- 0001540826
- Latest filing
- Jul 29, 2026
BMRN holding history
Biomarin Pharmaceutical Inc in every 13F filed by EULAV Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −38,000−100.0% | Sold out | Holders |
| Q2 2025 | 38,000 | $2.09M | <0.1% | −67,000−63.8% | Reduced | Holders |
| Q1 2025 | 105,000 | $7.42M | 0.2% | −3,000−2.8% | Reduced | Holders |
| Q4 2024 | 108,000 | $7.10M | 0.2% | −23,000−17.6% | Reduced | Holders |
| Q3 2024 | 131,000 | $9.21M | 0.2% | +15,000+12.9% | Added | Holders |
| Q2 2024 | 116,000 | $9.55M | 0.3% | −5,800−4.8% | Reduced | Holders |
| Q1 2024 | 121,800 | $10.6M | 0.3% | −8,200−6.3% | Reduced | Holders |
| Q4 2023 | 130,000 | $12.5M | 0.4% | −2,036−1.5% | Reduced | Holders |
| Q3 2023 | 132,036 | $11.7M | 0.4% | +37,000+38.9% | Added | Holders |
| Q2 2023 | 95,036 | $8.24M | 0.3% | +10,002+11.8% | Added | Holders |
| Q1 2023 | 85,034 | $8.27M | 0.3% | +2,034+2.5% | Added | Holders |
| Q4 2022 | 83,000 | $8.59M | 0.4% | +83,000 | New | Holders |